Media Center

Wed, 18 Jan 2023

Pathalys Pharma Raises $150 Million in Secured Product Financing and Equity led by Abingworth; Forms Strategic Collaboration with Launch Therapeutics to Advance Upacicalcet through Pivotal Phase 3 Studies

Mon, 15 Aug 2022

Launch Therapeutics partners with Opthea to advance OPT-302, a promising therapy for wet AMD

Mon, 11 APRIL 2022

Carlyle Expands Leading Healthcare Franchise with Agreement to Acquire Life Sciences Investment Firm Abingworth